CoChat

Challenges and prospects for pharmacotherapy in functional gastrointestinal disorders

Open access
Sanger, Gareth J., Lin Chang, Bountra, Chas, Houghton, Lesley A. · 2010 · Therapeutic Advances in Gastroenterology

The DOI matches its Crossref record; 135 of the 137 references it cites were found in a registry or an index.

Abstract

Functional gastrointestinal disorders, such as irritable bowel syndrome and functional dyspepsia, are complex conditions with multiple factors contributing to their pathophysiology. As a consequence they are difficult to treat and have posed significant challenges to the pharmaceutical industry when trying to develop new and effective treatments. This review provides an overview of these difficulties and how the industry is reshaping its drug developmental strategies. It describes some of the more significant and encouraging advances that have occurred, and discusses how future research might embrace the opportunities provided by advances in genetic and in particular, epigenetic research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/1756283x10369922

Cites

135 of 135 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 135 references

Research works printed but not linked: 12

  1. Camilleri, M., 2008, Am J Physiol, 295, G219
  2. Camilleri, M., 2008, Am J Physiol, 294, G13
  3. Dukes, G.E., 2009, Neurogastroenterol Motil, 21, 84
  4. Kelleher, D.L., 2008, Neurogastroenterol Motil, 20, 131
  5. 10.1111/j.1572-0241.2000.01766.x · DOI · Paper page
  6. Mayer, E.A., 2001, Am J Physiol Liver Physiol, 280, G519
  7. 10.1111/j.1572-0241.1998.440_j.x · DOI · Paper page
  8. Niesler, B., 2009, Eur J Gastroenterol Hepatol
  9. O’Mahony, S.M., 2010, Neurogastroenterol Motil
  10. Tahara, T., 2008, Hepatogastroenterol, 55, 979
  11. Takai, N., 2010, J Oncol, 458431
  12. Waterland, R.A., 2009, Horm Res, 71, 13

Cited by

See all 17

Metadata

Authors
Sanger, G. J., Chang, L., Bountra, C., & Houghton, L. A.
Affiliations
  • Queen Mary University of London (GB)
  • University of California, Los Angeles (US)
  • University of Oxford (GB)
  • University of Manchester (GB)
Venue
Therapeutic Advances in Gastroenterology
Published
2010-05-17
Volume
3
Issue
5
Pages
291-305
ISSN
  • 1756-283X (ISSN-L)
  • 1756-2848
OpenAlex
W1994281253
Cited by
17
References
137
Citations by year
2025: 2 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 2 · 2019: 1 · 2018: 1 · 2017: 1 · 2014: 1 · 2013: 3 · 2012: 1
FWCI
1.32
Type
journal article
Language
en
Open access
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Therapeutic Advances in Gastroenterology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
functional gastrointestinal disorders, irritable bowel syndrome, functional dyspepsia, pharmacotherapy, drug development, drug development strategy, epigenetics, genetic research, pathophysiology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Challenges and prospects for pharmacotherapy in functional gastrointestinal disorders. https://app.cochat.ai/papers/10.1177/1756283x10369922
The paper
Sanger, G. J., Chang, L., Bountra, C., & Houghton, L. A. (2010). Challenges and prospects for pharmacotherapy in functional gastrointestinal disorders. Therapeutic Advances in Gastroenterology. https://doi.org/10.1177/1756283x10369922

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.